Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2022, 4(11); doi: 10.25236/IJFM.2022.041104.

Anti-histamine Effects of Dipotassium Glycyrrhizinate on Airway Smooth Muscle Cell, Implicating Its Therapeutic Mechanism for Airway Hyperresponsiveness


Xuejiao Lian, Yang Yang, Jialing Tang, Xiuwen Li, Xiaoying Zhou

Corresponding Author:
Xiaoying Zhou

The School of Pharmacy, The School of Medicine, Changzhou University, Changzhou, Jiangsu, 213164, China


Asthma is a common respiratory disease, with chronic inflammatory associated with airway hyperresponsiveness (AHR). Airway smooth muscle (ASM) is the critical tissue modulating bronchial tension. Abnormal activation and proliferation of airway smooth muscle cells (ASMCs) are key process during airway problem development. Histamine, a mast-cell mediator, involves in allergy and air-way inflammation, and stimulates cells via its receptors. Dipotassium Glycyrrhizinate (DG) is a derivative of Glycyrrhizic acid, with anti-inflammation effects, but the effect of DG on histamine-induced ASMC has not discussed yet. Primary rats ASMCs were extracted to establish a histamine/cell-models to investigate the effects of DG on cells, and to explore the potential pharmaceutical mechanism of DG in the treatment of AHR. The data showed that DG inhibited histamine-induced cell proliferation, migration by suppressing P38/ERK and JAK/STAT signal pathway. The data also showed that DG up-regulated Bax expression and down-regulated Bcl-2 expression, leading to the apoptosis of activated ASMCs. Molecular docking analysis illustrated the high binding affinity of DG with histamine receptor, which is verified the antagonist function of DG on histamine by competing over histamine receptor. The present study suggests the anti-histamine function of DG and the underlying mechanism that DG can relieve airway hyper-responsiveness by inhibiting histamine-induced over-activation/proliferation and regulating airway smooth muscle cell intracellular signaling pathways. 


airway smooth muscle cells, histamine, dipotassium glycyrrhizinate, airway hyperresponsiveness

Cite This Paper

Xuejiao Lian, Yang Yang, Jialing Tang, Xiuwen Li, Xiaoying Zhou. Anti-histamine Effects of Dipotassium Glycyrrhizinate on Airway Smooth Muscle Cell, Implicating Its Therapeutic Mechanism for Airway Hyperresponsiveness. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 11: 22-30. https://doi.org/10.25236/IJFM.2022.041104.


[1] Knight J. M., Mak G., Shaw J., et al. (2015) Long-Acting Beta Agonists Enhance Allergic Airway Disease. PLoS One, 10, e0142212. https://doi.org/10.1371/journal.pone.0142212.

[2] Reber L. L., Sibilano R., Mukai K., Galli S. J. (2015) Potential effector and immunoregulatory functions of mast cells in mucosal immunity. Mucosal Immunol, 8, 444-463. https: // doi. org/ 10. 1038/ mi. 2014.131.

[3] Halwani R., Al-Abri J., Beland M., et al. (2011) CC and CXC chemokines induce airway smooth muscle proliferation and survival. J Immunol, 186, 4156-4163. https: // doi. org/ 10. 4049 /jimmunol. 1001210.

[4] Camoretti-Mercado B., Lockey R. F. (2021) Airway smooth muscle pathophysiology in asthma. J Allergy Clin Immunol, 147, 1983-1995. https://doi.org/10.1016/j.jaci.2021.03.035.

[5] Salter B., Pray C., Radford K., Martin J. G., Nair P. (2017) Regulation of human airway smooth muscle cell migration and relevance to asthma. Respir Res, 18, 156. https: // doi. org/ 10. 1186/ s12931-017-0640-8.

[6] Bara I., Ozier A., Tunon de Lara J. M., Marthan R., Berger P. (2010) Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J, 36, 1174-1184. https: // doi. org/ 10. 1183/ 09031936. 00019810.

[7] Hirota N., Risse P. A., Novali M., et al. (2012) Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells. Faseb j, 26, 1704-1716. https://doi.org/10.1096/fj.11-197061.

[8] Riza Y. M., Parves M. R., Tithi F. A., Alam S. (2019) Quantum chemical calculation and binding modes of H1R; a combined study of molecular docking and DFT for suggesting therapeutically potent H1R antagonist. In Silico Pharmacol, 7, 1. https://doi.org/10.1007/s40203-019-0050-3.

[9] Lin J. C. (2003) Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res, 59, 41-47. https://doi.org/10.1016/s0166-3542(03)00030-5.

[10] Wu Q., Tang Y., Hu X., et al. (2016) Regulation of Th1/Th2 balance through OX40/OX40L signalling by glycyrrhizic acid in a murine model of asthma. Respirology, 21, 102-111. https://doi.org/10.1111/resp.12655.

[11] Sun Z. G., Zhao T. T., Lu N., Yang Y. A., Zhu H. L. (2019) Research Progress of Glycyrrhizic Acid on Antiviral Activity. Mini Rev Med Chem, 19, 826-832. https: // doi. org/ 10. 2174/ 138955751966619 0119111125.

[12] Cinatl J., Morgenstern B., Bauer G., Chandra P. P., Doerr H. W. J. T. L. (2003) Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet, 361, 2045-2046. https://doi.org/10.1016/S0140-6736(03)13615-X.

[13] Chen L., Yang J., Davey A. K., et al. (2009) Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism. Xenobiotica, 39, 955-963. https://doi.org/10.3109/00498250903271997.

[14] Pinzi L., Rastelli G. (2019) Molecular Docking: Shifting Paradigms in Drug Discovery. Int J Mol Sci, 20, https://doi.org/10.3390/ijms20184331.

[15] Wei T., Liu L., Zhou X. (2018) Cortex Dictamni extracts inhibit over-proliferation and migration of rat airway smooth muscle cells via FAK/p38/Bcl-2 signaling pathway. Biomed Pharmacother, 102, 1-8. https://doi.org/10.1016/j.biopha.2018.03.039.

[16] Reed J. C. (2006) Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ, 13, 1378-1386. https: // doi. org/ 10. 1038/sj.cdd.4401975.

[17] Jove R. (2000) Preface: STAT signaling. Oncogene, 19, 2466-2467. https: // doi. org/ 10. 1038/ sj. onc. 1203549.

[18] Li S. M., Yao S. K., Yamamura N., Nakamura T. (2003) Expression of Bcl-2 and Bax in extrahepatic biliary tract carcinoma and dysplasia. World J Gastroenterol, 9, 2579-2582. https: // doi. org/ 10.3748/wjg.v9.i11.2579.

[19] Karmakar I., Haldar S., Chakraborty M., et al. (2016) Regulation of apoptosis through bcl-2/bax proteins expression and DNA damage by Zanthoxylum alatum. Pharm Biol, 54, 503-508. https://doi.org/10.3109/13880209.2015.1050675.

[20] Zhang Y., Wang Y., Zhou W., et al. (2019) A combined drug discovery strategy based on machine learning and molecular docking. Chem Biol Drug Des, 93, 685-699. https: // doi. org/ 10. 1111/ cbdd. 13494.